BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32150842)

  • 1. A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations.
    Su Z; Wu Y
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas.
    Gruss HJ; Dower SK
    Blood; 1995 Jun; 85(12):3378-404. PubMed ID: 7780126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
    Gruss HJ; Duyster J; Herrmann F
    Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational analyses of the interactome between TNF and TNFR superfamilies.
    Dhusia K; Su Z; Wu Y
    Comput Biol Chem; 2023 Apr; 103():107823. PubMed ID: 36682326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural principles of tumor necrosis factor superfamily signaling.
    Vanamee ÉS; Faustman DL
    Sci Signal; 2018 Jan; 11(511):. PubMed ID: 29295955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor family ligand-receptor binding.
    Zhang G
    Curr Opin Struct Biol; 2004 Apr; 14(2):154-60. PubMed ID: 15093829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Ligand-Receptor Interactions Using Bioluminescent TNF Superfamily (TNFSF) Ligand Fusion Proteins.
    Kucka K; Medler J; Wajant H
    Methods Mol Biol; 2021; 2248():185-200. PubMed ID: 33185876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I.
    Hildt E; Oess S
    J Exp Med; 1999 Jun; 189(11):1707-14. PubMed ID: 10359574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.
    Chan FK; Chun HJ; Zheng L; Siegel RM; Bui KL; Lenardo MJ
    Science; 2000 Jun; 288(5475):2351-4. PubMed ID: 10875917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational simulations of TNF receptor oligomerization on plasma membrane.
    Su Z; Wu Y
    Proteins; 2020 May; 88(5):698-709. PubMed ID: 31710744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
    Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
    Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF alpha and the TNF receptor superfamily: structure-function relationship(s).
    Idriss HT; Naismith JH
    Microsc Res Tech; 2000 Aug; 50(3):184-95. PubMed ID: 10891884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural basis for the recognition of diverse receptor sequences by TRAF2.
    Ye H; Park YC; Kreishman M; Kieff E; Wu H
    Mol Cell; 1999 Sep; 4(3):321-30. PubMed ID: 10518213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tools and techniques to study ligand-receptor interactions and receptor activation by TNF superfamily members.
    Schneider P; Willen L; Smulski CR
    Methods Enzymol; 2014; 545():103-25. PubMed ID: 25065888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily.
    Wu H
    Adv Protein Chem; 2004; 68():225-79. PubMed ID: 15500863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
    Liu LS; Spelleken M; Röhrig K; Hauner H; Eckel J
    Diabetes; 1998 Apr; 47(4):515-22. PubMed ID: 9568681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights of homotypic interaction domains in the ligand-receptor signal transduction of tumor necrosis factor (TNF).
    Park YH; Jeong MS; Jang SB
    BMB Rep; 2016 Mar; 49(3):159-66. PubMed ID: 26615973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
    Kajiwara K; Saito A; Ogata S; Tanihara M
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule inhibitors of the interaction between TNF and TNFR.
    Davis JM; Colangelo J
    Future Med Chem; 2013 Jan; 5(1):69-79. PubMed ID: 23256814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Virtual Screening of Tumor Necrosis Factor-α Inhibitors by Cheminformatics Approaches and Bio-Molecular Simulation.
    Halim SA; Sikandari AG; Khan A; Wadood A; Fatmi MQ; Csuk R; Al-Harrasi A
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.